Benzinga | Sep 20, 2021 08:39AM EDT

Sera Prognostics To Be Added To Russell 2000 Index

Sera Prognostics Inc., The Pregnancy Company(tm) (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that according to a preliminary list of initial public offering (IPO) additions to the Russell indexes, the company will be added to the Russell 2000 Index effective Sept. 20, 2021.

"We are pleased to be included in the Russell 2000 Index following our transition to a public company in July," said Gregory C. Critchfield, M.D., M.S., Chairman and CEO of Sera Prognostics. "This is the latest milestone for our company that will expand awareness of Sera within the investment community as we scale our PreTRM(r) test and expand revenue to build shareholder value."